Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma
Background The immune response within the tumor microenvironment plays a key role in tumorigenesis and determines the clinical outcomes of head and neck squamous cell carcinoma (HNSCC). However, to date, a paucity of robust, reliable immune-related biomarkers has been identified that are capable of...
Saved in:
| Main Authors: | Yun Chen, Ming Li, Yuan Zhang, Yao Yao, Zhongyi Yan, Senlin Lian, Liangnian Wei, Chao Zhou, Dongju Feng, Jianrong Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/2/e000444.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Head and Neck Squamous Cell Carcinoma: NT5E Could Be a Prognostic Biomarker
by: Yaoting Zhang, et al.
Published: (2022-01-01) -
Comprehensive analyses reveal the promising value of gasdermins as prognostic biomarkers and immunotherapeutic targets in head and neck squamous cell carcinoma
by: Huageng Huang, et al.
Published: (2025-01-01) -
Biomarkers in head and neck squamous cell carcinoma (HNSCC)-An update
by: Thirumalaikumaran R, et al.
Published: (2024-09-01) -
Prognostic and diagnostic value of SPINK mRNAs expression in head and neck squamous cell carcinoma based on genome-wide analysis
by: Chao Ma, et al.
Published: (2024-12-01) -
Prosaposin – A plausible biomarker in head and neck squamous cell carcinoma
by: Avradeep Datta, et al.
Published: (2024-03-01)